Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDay One Biopharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$0.93 | -$0.08 | -$0.28 |
| Q2 2026 | 5 | -$0.22 | -$0.09 | -$0.18 |
| Q3 2026 | 1 | -$0.18 | -$0.15 | -$0.16 |
| Q4 2026 | 1 | -$0.17 | -$0.14 | -$0.16 |
| Q1 2027 | 1 | -$0.20 | -$0.17 | -$0.18 |
| Q2 2027 | 1 | -$0.19 | -$0.16 | -$0.17 |
| Q3 2027 | 1 | -$0.15 | -$0.13 | -$0.14 |
| Q4 2027 | 1 | -$0.15 | -$0.13 | -$0.14 |
Day One Biopharmaceuticals Inc Earnings Date And Information
Day One Biopharmaceuticals Inc last posted its earnings results on Tuesday, May 5th, 2026. The company reported $-0.35 earnings per share for the quarter, missing analysts' consensus estimates of $-0.31 by $0.04. The company had revenue of 53.72 M for the quarter and had revenue of 158.18 M for the year. Day One Biopharmaceuticals Inc has generated $-1 earnings per share over the last year ($-1.04 diluted earnings per share) and currently has a price-to-earnings ratio of -20.74. Day One Biopharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Day One Biopharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 2025 | -$0.17 | -$0.21 | -0.04 | $49.85 M | $53.72 M |
| 11/04/2025 | Q3 2025 | -$0.28 | -$0.19 | 0.09 | $37.82 M | $39.80 M |
| 08/05/2025 | Q2 2025 | -$0.35 | -$0.29 | 0.06 | $34.93 M | $33.91 M |
| 05/06/2025 | Q1 2025 | -$0.46 | -$0.35 | 0.11 | $30.27 M | $30.76 M |
| 02/25/2025 | Q4 2024 | -$0.35 | -$0.70 | -0.35 | $27.83 M | $29.21 M |
| 10/30/2024 | Q3 2024 | -$0.41 | $0.38 | 0.79 | $28.48 M | $93.76 M |
| 08/02/2024 | Q2 2024 | N/A | -$0.05 | N/A | $1.03 M | $8.19 M |
| 05/06/2024 | Q1 2024 | -$0.67 | -$0.72 | -0.05 | N/A | $0 |
| 02/26/2024 | Q4 2023 | -$0.57 | -$0.62 | -0.05 | N/A | $0 |
| 11/06/2023 | Q3 2023 | -$0.60 | -$0.54 | 0.06 | N/A | $0 |
| 08/07/2023 | Q2 2023 | -$0.60 | -$0.61 | -0.01 | N/A | $0 |
| 05/01/2023 | Q1 2023 | -$0.60 | -$0.49 | 0.11 | N/A | $0 |
| 03/06/2023 | Q4 2022 | -$0.57 | -$0.47 | 0.1 | N/A | $0 |
| 11/07/2022 | Q3 2022 | -$0.53 | -$0.48 | 0.05 | N/A | $0 |
| 08/04/2022 | Q2 2022 | -$0.49 | -$0.60 | -0.11 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.39 | -$0.48 | -0.09 | N/A | $0 |
| 03/07/2022 | Q4 2021 | -$0.36 | -$1.93 | -1.57 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.28 | -$0.31 | -0.03 | N/A | $0 |
| 08/10/2021 | Q2 2021 | -$0.31 | -$0.23 | 0.08 | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.25 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Day One Biopharmaceuticals Inc Earnings: FAQ's
The conference call for Day One Biopharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Day One Biopharmaceuticals Inc's latest earnings report can be read online.
Day One Biopharmaceuticals Inc (:DAWN) has a recorded annual revenue of $158.18 M.
Day One Biopharmaceuticals Inc (:DAWN) has a recorded net income of $-107,322,000.Day One Biopharmaceuticals Inc has generated $-1.04 earnings per share over the last four quarters.
Day One Biopharmaceuticals Inc (:DAWN) has a price-to-earnings ratio of -20.74 and price/earnings-to-growth ratio is 0.4.